Bexlosteride
From Wikipedia, the free encyclopedia
 | |
|---|---|
| Systematic (IUPAC) name | |
| (4aS,10bR)-8-chloro-4-methyl-1,2,4a,5,6,10b-hexahydrobenzo[f]quinolin- | |
| Clinical data | |
| Legal status | Uncontrolled |
| Routes | Oral |
| Identifiers | |
| CAS number | 202189-78-4  |
| ATC code | None |
| PubChem | CID 166562 |
| ChemSpider | 145762  |
| UNII | 36X732P4P0 |
| ChEMBL | CHEMBL24955 |
| Chemical data | |
| Formula | C14H16ClNO |
| Mol. mass | 249.73594 g/mol |
| SMILES
| |
| |
| (what is this?) (verify) | |
Bexlosteride (LY-191,704) is a potent and noncompetitive inhibitor of the enzyme 5α-reductase related to finasteride and dutasteride.[1][2] It is selective for the type I isoform of the enzyme.[1] It was never marketed.
See also
References
- ↑ 1.0 1.1 Chang, Chawnshang (2002). Androgens and androgen receptor : mechanisms, functions, and clinical application. Boston: Kluwer Academic Publishers. ISBN 1-4020-7188-4.
- ↑ Lednicer, Daniel (2008). Strategies for Organic Drug Synthesis and Design. New York: Wiley-Interscience. ISBN 0-470-19039-6.
| |||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.